{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T18:42:54Z","timestamp":1790534574145,"version":"4.1.0"},"reference-count":65,"publisher":"MDPI AG","issue":"3","license":[{"start":{"date-parts":[[2022,1,24]],"date-time":"2022-01-24T00:00:00Z","timestamp":1642982400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cells"],"abstract":"<jats:p>GABA depolarizes and often excites immature neurons in all animal species and brain structures investigated due to a developmentally regulated reduction in intracellular chloride concentration ([Cl\u2212]i) levels. The control of [Cl\u2212]i levels is mediated by the chloride cotransporters NKCC1 and KCC2, the former usually importing chloride and the latter exporting it. The GABA polarity shift has been extensively validated in several experimental conditions using often the NKCC1 chloride importer antagonist bumetanide. In spite of an intrinsic heterogeneity, this shift is abolished in many experimental conditions associated with developmental disorders including autism, Rett syndrome, fragile X syndrome, or maternal immune activation. Using bumetanide, an EMA- and FDA-approved agent, many clinical trials have shown promising results with the expected side effects. Kaila et al. have repeatedly challenged these experimental and clinical observations. Here, we reply to the recent reviews by Kaila et al. stressing that the GABA polarity shift is solidly accepted by the scientific community as a major discovery to understand brain development and that bumetanide has shown promising effects in clinical trials.<\/jats:p>","DOI":"10.3390\/cells11030396","type":"journal-article","created":{"date-parts":[[2022,1,25]],"date-time":"2022-01-25T20:44:33Z","timestamp":1643143473000},"page":"396","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":25,"title":["The GABA Polarity Shift and Bumetanide Treatment: Making Sense Requires Unbiased and Undogmatic Analysis"],"prefix":"10.3390","volume":"11","author":[{"given":"Yehezkel","family":"Ben-Ari","sequence":"first","affiliation":[{"name":"Neurochlore, Batiment Beret Delaage, Campus Scientifique de Luminy, 13009 Marseille, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1183-2772","authenticated-orcid":false,"given":"Enrico","family":"Cherubini","sequence":"additional","affiliation":[{"name":"European Brain Research Institute (EBRI)-Rita Levi-Montalcini, 00161 Roma, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2022,1,24]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-017-01814-0","article-title":"The neuronal K+Cl\u2212 co-transporter 2 (Slc12a5) modulates insulin secretion","volume":"7","author":"Kursan","year":"2017","journal-title":"Sci. Rep."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1523\/JNEUROSCI.04-03-00860.1984","article-title":"Development of hyperpolarizing inhibitory postsynaptic potentials and hyperpolarizing response to gamma-aminobutyric acid in rabbit hippocampus studied in vitro","volume":"4","author":"Mueller","year":"1984","journal-title":"J. Neurosci."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/0006-8993(83)90500-0","article-title":"Evidence for late development of inhibition in area CA1 of the rat hippocampus","volume":"268","author":"Harris","year":"1983","journal-title":"Brain Res."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1159\/000112753","article-title":"Age-Related Differences in the in vitro Rat Hippocampus","volume":"4","author":"Dunwiddie","year":"1981","journal-title":"Dev. Neurosci."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1152\/physrev.00017.2006","article-title":"GABA: A Pioneer Transmitter That Excites Immature Neurons and Generates Primitive Oscillations","volume":"87","author":"Gaiarsa","year":"2007","journal-title":"Physiol. Rev."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"3967","DOI":"10.1073\/pnas.0305974101","article-title":"From The Cover: GABA-mediated giant depolarizing potentials as coincidence detectors for enhancing synaptic efficacy in the developing hippocampus","volume":"101","author":"Kasyanov","year":"2004","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1126\/science.aac6472","article-title":"A GABAergic projection from the zona incerta to cortex promotes cortical neuron development","volume":"350","author":"Chen","year":"2015","journal-title":"Science"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1038\/nrn920","article-title":"Excitatory actions of gaba during development: The nature of the nurture","volume":"3","year":"2002","journal-title":"Nat. Rev. Neurosci."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"13176","DOI":"10.1073\/pnas.0704533104","article-title":"Correlated network activity enhances synaptic efficacy via BDNF and the ERK pathway at immature CA3 CA1 connections in the hippocampus","volume":"104","author":"Mohajerani","year":"2007","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1038\/16697","article-title":"The K+\/Cl\u2212 co-transporter KCC2 renders GABA hyperpolarizing during neuronal maturation","volume":"397","author":"Rivera","year":"1999","journal-title":"Nature"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1113\/jphysiol.1989.sp017762","article-title":"Giant synaptic potentials in immature rat CA3 hippocampal neurones","volume":"416","author":"Cherubini","year":"1989","journal-title":"J. Physiol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1038\/s43587-021-00122-7","article-title":"Experimental and real-world evidence supporting the computational repurposing of bumetanide for APOE4-related Alzheimer\u2019s disease","volume":"1","author":"Taubes","year":"2021","journal-title":"Nat. Aging"},{"key":"ref_13","first-page":"35","article-title":"Refuting the challenges of the developmental shift of polarity of GABA actions: GABA more exciting than ever!","volume":"6","author":"Woodin","year":"2012","journal-title":"Front. Cell Neurosci."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"15638","DOI":"10.1523\/JNEUROSCI.3355-10.2010","article-title":"Spontaneous Network Events Driven by Depolarizing GABA Action in Neonatal Hippocampal Slices are Not Attributable to Deficient Mitochondrial Energy Metabolism","volume":"30","author":"Ruusuvuori","year":"2010","journal-title":"J. Neurosci."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"5961","DOI":"10.1523\/JNEUROSCI.3482-15.2016","article-title":"An Optogenetic Approach for Investigation of Excitatory and Inhibitory Network GABA Actions in Mice Expressing Channelrhodopsin-2 in GABAergic Neurons","volume":"36","author":"Valeeva","year":"2016","journal-title":"J. Neurosci."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"7750","DOI":"10.1038\/ncomms8750","article-title":"GABA depolarizes immature neurons and inhibits network activity in the neonatal neocortex in vivo","volume":"6","author":"Kirmse","year":"2015","journal-title":"Nat. Commun."},{"key":"ref_17","first-page":"E8770","article-title":"Simultaneous two-photon imaging of intracellular chloride concentration and pH in mouse pyramidal neurons in vivo","volume":"114","author":"Sato","year":"2017","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"1394","DOI":"10.1152\/jn.01126.2007","article-title":"Effect of Common Anesthetics on Dendritic Properties in Layer 5 Neocortical Pyramidal Neurons","volume":"99","author":"Potez","year":"2008","journal-title":"J. Neurophysiol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"eaba1430","DOI":"10.1126\/sciadv.aba1430","article-title":"GABAergic interneurons excite neonatal hippocampus in vivo","volume":"6","author":"Murata","year":"2020","journal-title":"Sci. Adv."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"1788","DOI":"10.1126\/science.1133212","article-title":"Maternal oxytocin triggers a transient inhibitory switch in GABA signaling in the fetal brain during delivery","volume":"314","author":"Tyzio","year":"2006","journal-title":"Science"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"E10819","DOI":"10.1073\/pnas.1717337114","article-title":"Vasopressin excites interneurons to suppress hippocampal network activity across a broad span of brain maturity at birth","volume":"114","author":"Spoljaric","year":"2017","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"254","DOI":"10.3389\/fncel.2018.00254","article-title":"Oxytocin and Vasopressin, and the GABA Developmental Shift during Labor and Birth: Friends or Foes?","volume":"12","year":"2018","journal-title":"Front Cell Neurosci."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"10372","DOI":"10.1523\/JNEUROSCI.19-23-10372.1999","article-title":"The Establishment of GABAergic and Glutamatergic Synapses on CA1 Pyramidal Neurons is Sequential and Correlates with the Development of the Apical Dendrite","volume":"19","author":"Tyzio","year":"1999","journal-title":"J. Neurosci."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"2964","DOI":"10.1152\/jn.00172.2003","article-title":"Membrane Potential of CA3 Hippocampal Pyramidal Cells During Postnatal Development","volume":"90","author":"Tyzio","year":"2003","journal-title":"J. Neurophysiol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-019-45635-9","article-title":"Early alterations in a mouse model of Rett syndrome: The GABA developmental shift is abolished at birth","volume":"9","author":"Lozovaya","year":"2019","journal-title":"Sci. Rep."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1126\/science.1247190","article-title":"Oxytocin-Mediated GABA Inhibition during Delivery Attenuates Autism Pathogenesis in Rodent Offspring","volume":"343","author":"Tyzio","year":"2014","journal-title":"Science"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"3982","DOI":"10.1093\/cercor\/bhy279","article-title":"The GABA Developmental Shift Is Abolished by Maternal Immune Activation Already at Birth","volume":"29","author":"Fernandez","year":"2018","journal-title":"Cereb. Cortex"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.celrep.2016.03.013","article-title":"The timing of the excitatory-to-inhibitory GABA switch is regulated by the oxytocin receptor via KCC2","volume":"15","author":"Leonzino","year":"2016","journal-title":"Cell Rep."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/S0006-3223(97)00439-3","article-title":"Plasma oxytocin levels in autistic children","volume":"43","author":"Modahl","year":"1998","journal-title":"Biol. Psychiatry"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.biopsych.2011.12.025","article-title":"Sensitive Parenting Is Associated with Plasma Oxytocin and Polymorphisms in the OXTR and CD38 Genes","volume":"72","author":"Feldman","year":"2012","journal-title":"Biol. Psychiatry"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"8119","DOI":"10.1073\/pnas.1705521114","article-title":"Intranasal oxytocin treatment for social deficits and biomarkers of response in children with autism","volume":"114","author":"Parker","year":"2017","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1093\/brain\/awr041","article-title":"Neuronal chloride accumulation and excitatory GABA underlie aggravation of neonatal epileptiform activities by phenobarbital","volume":"134","author":"Nardou","year":"2011","journal-title":"Brain"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"9866","DOI":"10.1523\/JNEUROSCI.2761-07.2007","article-title":"Perturbed Chloride Homeostasis and GABAergic Signaling in Human Temporal Lobe Epilepsy","volume":"27","author":"Huberfeld","year":"2007","journal-title":"J. Neurosci."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"244ra89","DOI":"10.1126\/scitranslmed.3008065","article-title":"Cortical GABAergic excitation contributes to epileptic activities around human glioma","volume":"6","author":"Pallud","year":"2014","journal-title":"Sci. Transl. Med."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1016\/j.tins.2017.07.001","article-title":"NKCC1 Chloride Importer Antagonists Attenuate Many Neurological and Psychiatric Disorders","volume":"40","year":"2017","journal-title":"Trends Neurosci."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1038\/nrn3819","article-title":"Cation-chloride cotransporters in neuronal development, plasticity and disease","volume":"15","author":"Kaila","year":"2014","journal-title":"Nat. Rev. Neurosci."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1002\/ana.25959","article-title":"A pilot randomized, controlled, double-blind trial of bumetanide to treat neonatal seizures","volume":"89","author":"Soul","year":"2021","journal-title":"Ann. Neurol."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"e202","DOI":"10.1038\/tp.2012.124","article-title":"A randomised controlled trial of bumetanide in the treatment of autism in children","volume":"2","author":"Lemonnier","year":"2012","journal-title":"Transl. Psychiatry"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"1885","DOI":"10.1111\/j.1651-2227.2010.01933.x","article-title":"The diuretic bumetanide decreases autistic behaviour in five infants treated during 3 months with no side effects","volume":"99","author":"Lemonnier","year":"2010","journal-title":"Acta Paediatratica"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1016\/j.scib.2021.01.008","article-title":"Improved symptoms following bumetanide treatment in children aged 3\u22126 years with autism spectrum disorder: A randomized, double-blind, placebo-controlled trial","volume":"66","author":"Dai","year":"2021","journal-title":"Sci. Bull."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"e1056","DOI":"10.1038\/tp.2017.10","article-title":"Effects of bumetanide on neurobehavioral function in children and adolescents with autism spectrum disorders","volume":"7","author":"Lemonnier","year":"2017","journal-title":"Transl. Psychiatry"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"1548","DOI":"10.1111\/apa.15723","article-title":"Bumetanide for autism: Open-label trial in six children","volume":"110","author":"Fernell","year":"2020","journal-title":"Acta Paediatr."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1089\/cap.2015.0045","article-title":"A Pilot Study on the Combination of Applied Behavior Analysis and Bumetanide Treatment for Children with Autism","volume":"25","author":"Du","year":"2015","journal-title":"J. Child Adolesc. Psychopharmacol."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1038\/s41398-020-0692-2","article-title":"Symptom improvement in children with autism spectrum disorder following bumetanide administration is associated with decreased GABA\/glutamate ratios","volume":"10","author":"Zhang","year":"2020","journal-title":"Transl. Psychiatry"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1016\/j.jaac.2020.07.888","article-title":"Bumetanide for Core Symptoms of Autism Spectrum Disorder (BAMBI): A Single Center, Double-Blinded, Participant-Randomized, Placebo-Controlled, Phase-2 Superiority Trial","volume":"60","author":"Sprengers","year":"2020","journal-title":"J. Am. Acad. Child Adolesc. Psychiatry"},{"key":"ref_46","first-page":"971","article-title":"Bumetanide in the management of autism. Tunisian experience in Razi Hospital | Le bum\u00e9tanide dans l\u2019autisme. Exp\u00e9rience pilote du service de p\u00e9dopsychiatrie de l\u2019h\u00f4pital Razi Tunisie","volume":"97","author":"Hajri","year":"2019","journal-title":"Tuinisie Med."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1177\/1060028018817304","article-title":"Bumetanide for autism spectrum Disorder in children: A review of Randomized controlled trials. Annals of pharmacol","volume":"53","author":"James","year":"2019","journal-title":"Ann. Pharmacother."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"751575","DOI":"10.3389\/fpsyt.2021.751575","article-title":"Treatment effect of bumetanide in children with autism spectrum disorder: A systematic review and meta-analysis","volume":"12","author":"Wang","year":"2021","journal-title":"Front. Psychiatry"},{"key":"ref_49","unstructured":"Juarez-Martinez, E.L., Sprengers, J.J., Cristian, G., Oranje, B., van Andel, D.M., Avramiea, A.E., Simpraga, S., Houtman, S.J., Hardstone, R., and Gerver, C. (2021). Prediction of Behavioral Improvement through Resting-State Electroencephalography and Clinical Severity in a Randomized Controlled Trial Testing Bumetanide in Autism Spectrum Disorder. Biol. Psychiatry Cogn. Neurosci. Neuroimaging."},{"key":"ref_50","first-page":"1","article-title":"Effects of bumetanide on neurodevelopmental impairments in patients with tuberous sclerosis complex: An open-label pilot study","volume":"11","author":"Sprengers","year":"2020","journal-title":"Mol. Autism"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-017-03378-5","article-title":"Look me in the eyes: Constraining gaze in the eye-region provokes abnormally high subcortical activation in autism","volume":"7","author":"Hadjikhani","year":"2017","journal-title":"Sci. Rep."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"3602","DOI":"10.1038\/s41598-018-21958-x","article-title":"Bumetanide for autism: More eye contact, less amygdala activation","volume":"8","author":"Hadjikhani","year":"2018","journal-title":"Sci. Rep."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"e539","DOI":"10.1542\/peds.2014-4133","article-title":"Paradoxical benzodiazepine response: A rationale for bumetanide in neurodevelopmental disorders?","volume":"136","author":"Bruining","year":"2015","journal-title":"Pediatrics"},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1111\/epi.16866","article-title":"Reply to the commentary by Ben-Ari and Delpire: Bumetanide and neonatal seizures: Fiction versus reality","volume":"62","author":"Kaila","year":"2021","journal-title":"Epilepsia"},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.neuropharm.2018.09.025","article-title":"Bumepamine, a brain-permeant benzylamine derivative of bumetanide, does not inhibit NKCC1 but is more potent to enhance phenobarbital\u2019s anti-seizure efficacy","volume":"143","author":"Brandt","year":"2018","journal-title":"Neuropharmacology"},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.neuropharm.2012.05.045","article-title":"Cation-chloride cotransporters NKCC1 and KCC2 as potential targets for novel antiepileptic and antiepileptogenic treatments","volume":"69","author":"Puskarjov","year":"2013","journal-title":"Neuropharmacology"},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1016\/j.jpeds.2013.06.012","article-title":"Factors Associated with Permanent Hearing Impairment in Infants Treated with Therapeutic Hypothermia","volume":"163","author":"Smit","year":"2013","journal-title":"J. Pediatr."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/S1474-4422(14)70303-5","article-title":"Bumetanide for the treatment of seizures in newborn babies with hypoxic ischaemic encephalopathy (NEMO): An open-label, dose finding, and feasibility phase 1\/2 trial","volume":"14","author":"Pressler","year":"2015","journal-title":"Lancet Neurol."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"133664","DOI":"10.1016\/j.neulet.2018.06.033","article-title":"Blood-brain barrier regulation in psychiatric disorders","volume":"726","author":"Kealy","year":"2018","journal-title":"Neurosci. Lett."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1038\/nrneurol.2017.188","article-title":"Blood\u2013brain barrier breakdown in Alzheimer disease and other neurodegenerative disorders","volume":"14","author":"Sweeney","year":"2018","journal-title":"Nat. Rev. Neurol."},{"key":"ref_61","first-page":"125","article-title":"Diabetes Mellitus and Blood-Brain Barrier Dysfunction: An Overview","volume":"2","author":"Prasad","year":"2014","journal-title":"J. Pharmacovigil."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"3097","DOI":"10.1113\/jphysiol.2008.153148","article-title":"Molecular, pharmacological and functional properties of GABAA receptors in anterior pituitary cells","volume":"586","author":"Zemkova","year":"2018","journal-title":"J. Physiol."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/2040-2392-2-16","article-title":"Investigation of the serum levels of anterior pituitary hormones in male children with autism","volume":"2","author":"Iwata","year":"2011","journal-title":"Mol. Autism"},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-021-86320-0","article-title":"Machine learning analysis of pregnancy data enables early identification of a subpopulation of newborns with ASD","volume":"11","author":"Caly","year":"2021","journal-title":"Sci. Rep."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1016\/j.tins.2008.09.002","article-title":"Neuro-archaeology: Pre-symptomatic architecture and signature of neurological disorders","volume":"31","year":"2008","journal-title":"Trends Neurosci."}],"container-title":["Cells"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2073-4409\/11\/3\/396\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T22:06:46Z","timestamp":1760134006000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2073-4409\/11\/3\/396"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1,24]]},"references-count":65,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2022,2]]}},"alternative-id":["cells11030396"],"URL":"https:\/\/doi.org\/10.3390\/cells11030396","relation":{},"ISSN":["2073-4409"],"issn-type":[{"value":"2073-4409","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,1,24]]}}}